Products / Services

Product Profile

Platelet Transfusion
Platelet transfusions are required for the treatment or prevention of bleeding due to reduced platelet numbers or function. In general, the risk of bleeding increases only when the platelet count falls to below 50x10⁹/l and spontaneous bleeding seldom occurs at platelet counts above 20x10⁹/l. read more

Leucocyte Depleted Blood Components
Leucocytes in blood components are responsible for a number of adverse effects associated with blood transfusion. The pathogenesis has not been precisely elucidated in many instances but it is likely that it is immunologically mediated. Potential mechanisms include clonal deletion or anergy, induction of suppressor cells, production of anti-idiotypic antibody and suppression of NK cell activity among others. read more

Gamma Irradiation of Blood Products
Transfusion-associated graft-versus-host disease (TA-GVHD) is a potential complication of the transfusion of any blood component containing viable T-lymphocytes. Under certain conditions these cells engraft and proliferate in the recipient. Cellular interaction between donor T lymphocytes and recipient cells leads to cellular damage (particularly the skin, thymus, gastro-intestinal tract, liver, spleen and bone marrow) leading to clinical consequences which are often fatal. read more

Paediatric Transfusion Products
The field of transfusion medicine for children shares most of the same principles as that of adults but it has distinctive features which need separate consideration. Those children who require blood products are also among the most intensively transfused of all patients. Because they are likely to have a long lifespan following transfusion, minimising adverse events is of great importance.read more

Plasma Components and Derivatives
There is a wide range of plasma products available with specific indications for their use. For the purpose of clarity, products produced by the component processing laboratories and relying on purely physical separation techniques will be defined as plasma components (e.g. fresh frozen plasma, cryoprecipitate). Those products derived from plasma pools and subjected to more complex chemico-physical processing (e.g. Kistler and Nistchmann alcohol fractionation method) will be referred to as plasma derivatives (e.g. albumin). read more

Red Cell Products WHOLE BLOOD
The transfusion of red cells has the ability to save lives and markedly improve survival rates and morbidity in patients being treated for a wide range of medical and surgical conditions. A review of patients who declined blood transfusion showed an increasing morbidity and mortality in proportion to reducing haemoglobin level below 8g/dl. Therefore, for each patient, depending on co-morbidities, a transfusion threshold for red cell transfusion should be determined. read more